2010
DOI: 10.1242/dmm.003707
|View full text |Cite
|
Sign up to set email alerts
|

Loss of fibulin-5 binding to β1 integrins inhibits tumor growth by increasing the level of ROS

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
39
1

Year Published

2010
2010
2022
2022

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 55 publications
(40 citation statements)
references
References 40 publications
0
39
1
Order By: Relevance
“…The mechanisms underlying the prosurvival properties of FBLN5 remain complex and not well understood. Recently, it has been described that FBLN5 regulates reactive oxygen species production in endothelial cells (50). Furthermore, FBLN5 is able to activate integrin signaling, involved in cell survival (57,58), although, as we mentioned above, in some scenarios, it has been postulated as an integrin antagonist.…”
Section: Discussionmentioning
confidence: 90%
See 1 more Smart Citation
“…The mechanisms underlying the prosurvival properties of FBLN5 remain complex and not well understood. Recently, it has been described that FBLN5 regulates reactive oxygen species production in endothelial cells (50). Furthermore, FBLN5 is able to activate integrin signaling, involved in cell survival (57,58), although, as we mentioned above, in some scenarios, it has been postulated as an integrin antagonist.…”
Section: Discussionmentioning
confidence: 90%
“…In addition, mutations in the FBLN5 gene are related with macular degeneration and severe forms of cutis laxa (44,45). Interestingly, FBLN5 acts as a multifunctional protein involved in cell-cell and matrix-cell signaling pathways key for vascular cell proliferation, adhesion, and migration (11, 15, 17, 46 -48), as well as for vascular redox state (49,50) and synthesis of ECM proteases (51,52). Our current work demonstrates that hypoxic stress induces FBLN5 expression in vascular endothelial cells (human, bovine, or mouse endothelial cells), an effect that is extensive to other cell types.…”
Section: Discussionmentioning
confidence: 99%
“…However, fibulin-5 fails to activate downstream signalling after binding to α 5 β 1 and α 4 β 1 integrins, suggesting that fibulin-5 may act in a dominant-negative fashion to inhibit fibronectin receptor-mediated signalling. On the other hand, loss of fibulin-5 binding to β 1-integrins prevents pancreatic tumour growth by increasing the levels of ROS (reactive oxygen species) [49]. These results suggest that readouts of the cross-talk between fibulin-5 and different subsets of integrins are cell-type-and context-specific.…”
Section: Discussionmentioning
confidence: 99%
“…Direct evidence has been reported linking FBLN 5 to angiogenesis and regarding FBLN 5 as an endogenous inhibitor of angiogenesis and endothelial cell activities [22,24]. VEGF, a key regulator of vascu logenesis and angiogenesis, dramatically down regu lates FBLN 5 expression, suggesting that reduced FBLN 5 expression is necessary for angiogenesis acti vation [11].…”
Section: Fbln 5 and Angiogenesismentioning
confidence: 99%
“…In endothelial cells, FBLN 5 expression prevents the activation of ERK1/2 and p38 MAPK, but promotes angiogenesis resolution by targeting TSP 1, a natural inhibitor of neovascularization and tumorigenesis [11]. FBLN 5 binds to β1 integrins to activate integrin induced ROS production, representing the underlying cause for the reduction in angiogenesis and tumor growth [24]. On the other hand, FBLN 5 antagonizes fibronectin induced stress fiber formation and focal adhesion in smooth muscle cell by binding to α5β1 and α4β inte grins, but fails to activate downstream signaling [13], suggesting that FBLN 5 acts in a dominant negative role to inhibit fibronectin receptor mediated signal ing.…”
Section: Fbln 5 and Angiogenesismentioning
confidence: 99%